In vitro, both RBX1 and FBXW8 KD resulted in a significant decrease in the SFE and OFE of NUMB‐deficient T1 and T2 BC cells, while no effects were observed in NUMB‐proficient TA and TB BC cells (Figure8a,b). Here, RBX1 is linked to breast cancer.